Product Image

Contributor Information

  • Name Abey Bandara
  • Institute Virginia Tech

Tool Details

  • Tool name: Mitochondrial complex II mutated SDHD cell line
  • Alternate names: HEK293?SDHD
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: HEK293
  • Organism: Human
  • Disease: Mitochondrial disease; complex II deficiency; Paraganglioma
  • Description: The HEK293?SDHD cell line expresses a CRISPR/Cas9 mutated nuclear encoded subunit, SDHD, of mitochondrial complex II (succinate dehydrogenase). This cell line has been shown to significantly alter the function of complex II (CII) of the mitochondrial electron transport chain and displays disruptions to SDHD that mimic clinical presentations of CII deficiency. These cells represent a powerful model of metabolic pathologies, not only for mitochondrial disease, but also for understanding the importance of CII in developing novel therapeutics. Specific disruptions in SDHD have been reported to present clinically as the following disease conditions: -Complex II deficiency -Paraganglioma
  • Research area: Cancer ; Drug Discovery & Development ; Metabolism
  • Additional notes: Cancer Research Technology Limited (trading research tools as has been granted a non-exclusive license to the CRISPR-Cas9 technology by ERS Genomics Ltd under the patent rights listed here: This license from ERS Genomics Ltd allows to develop and commercialise CRISPR-Cas9 modified cell lines for research use only. can provide these modified CRISPR-Cas9 cell lines to companies under a label-use only license

  • For Research Use Only

Target Details

Application Details


  • Format: Frozen
  • Growth medium: DMEM medium supplemented with 10% Fetal Bovine Serum and 1% Penicillin-Streptomycin at 37°C temperature and 5-6% CO2.
  • Shipping conditions: Dry ice


  • Available on request


  •   Bandara et al. 2021. BMC Mol Cell Biol. 22(1):35. PMID: 34118887.